Video

Dr. Garner Discusses the myRisk Hereditary Cancer Test

Elizabeth Garner, MD, MPH, vice president, Clinical Affairs, Preventive Care, Myriad Genetics, discusses the myRisk Hereditary Cancer Test.

Elizabeth Garner, MD, MPH, vice president, Clinical Affairs, Preventive Care, Myriad Genetics, discusses the myRisk Hereditary Cancer Test.

Garner explains that myRisk is a genetic test that looks for mutations in 25 genes that are known to be associated with significantly elevated risk for cancer. There are eight major cancers that the test can detect, such as breast cancer, ovarian cancer, melanoma, and endometrial cancer.

The test allows physicians to increase the rate of detection for individuals that have mutations or who have hereditary cancer syndromes, Garner says. The increased ability to detect these patients allows these patients to better manage their health, in order to reduce their risk of developing cancer.

<<<

View more from the 2013 SABCS Meeting

Related Videos
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Benjamin P. Levy, MD, with Kristie Kahl and Andrew Svonavec
Sheldon M. Feldman, MD
Dana Zakalik, MD
Alberto Montero, MD, MBA, CPHQ
Jairam Krishnamurthy, MD, FACP